The Guggenheim Museum Bilbao launches its new in situ series with Living Architecture: Gehry, a digital installation by Refik Anadol. Using a custom AI model trained on Frank Gehry’s sketches ...

Gehry, at the Guggenheim Museum Bilbao—projected on the towering interior walls of Frank Gehry’s architectural masterpiece as part of the exhibition in situ: Refik Anadol—is to be reminded ...

EMD Serono is the North American drug development business of Merck KGaA, Darmstadt, Germany. A couple of months later, the company announced that President Chris Round would retire, and be ...

With the CSF-1R inhibitor space heating up, Merck KGaA has gone all-in on pimicotinib, paying Abbisko Therapeutics $85 million to secure the global license to the drug. The German pharma ...

40% of Merck & Co., Inc.'s revenues are driven by cancer med Keytruda, which faces patent expiry by 2028, posing a significant risk to future earnings and share price value. The company is ...

Merck's stock trades at a low valuation as investors worry about Keytruda's looming patent cliff. The company is looking to a new, subcutaneous formulation, which could help sales remain strong ...

At its sprawling complex in Durham, N.C., Merck has opened a new $1 billion, 225,000-square-foot manufacturing plant slated to produce bulk substance for its megablockbuster HPV vaccine Gardasil.

March 11 (Reuters) - Merck (MRK.N), opens new tab said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S. manufacturing amid ...

The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a 225,000-square-foot addition to the company’s existing campus off Old Oxford Road.

When EMD Serono embarked on a campaign to empower patients living ... which are produced by the healthcare business unit of Merck KGaA. Launched on Super Bowl Sunday, the campaign includes a 60-second ...

A federal judge in North Carolina on Tuesday granted an order for summary judgment in favor of Merck (NYSE:MRK) regarding lawsuits accusing the drugmaker of failing to warn consumers its Gardasil ...

March 11 (Reuters) - A federal judge ruled in favor of Merck (MRK.N), opens new tab in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers ...